Bank of New York Mellon Corp Grows Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV)
Bank of New York Mellon Corp increased its stake in Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) by 2.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 220,502 shares of the company’s stock after acquiring an additional 5,262 shares during the quarter. Bank of New York Mellon Corp’s holdings in Verve Therapeutics […]
